on the basis of our observation of the increased specific activities of glutamine-utilizing enzymes in purine and pyrimidine metabolism in hepatoma 3924a , and because the concentration of glutamine is ten times lower in the hepatomas than in the liver , the biochemical pharmacology of the anti-glutamine agent , acivicin , was examined .
C2239176
hepatomas
C0023884
liver